Status:
ACTIVE_NOT_RECRUITING
Mindfulness Meditation Intervention Study
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Total Knee Replacement
Mediation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pilot study is to develop a randomized control trial study with sufficient power to definitely address if a preop mindfulness meditation intervention can improve post-total knee arthr...
Detailed Description
This study will investigate the effect of a preoperative mindfulness meditation intervention (MMI) on outcomes for total knee arthroplasty (TKA) patients at the Hospital for Special Surgery in a rando...
Eligibility Criteria
Inclusion
- Adult patients undergoing primary total knee arthroplasty with a participating surgeon
- Patients on these medications for anxiety/depression: Fluoxetine, Paroxetine, Citalopram, Escitalopram, Sertraline, Fluvoxamine, Venlafaxine, Duloxetine, Levomilnacipran, Desvenlafaxine, Bupropion, Mirtazapine, Amitriptyline, Nortriptyline, Clonazepam, Alprazolam, Lorazepam, Diazepam, Oxazepam, Chlordiazepoxide
- Patients receiving intraoperative auricular acupuncture as part of participating surgeon's preferred anesthetic care
- Patients fluent in English
- ASA I-III
- BMI \< 40
Exclusion
- Patient not fluent in English (inability to understand the intervention video will likely affect ability to utilize the mindfulness techniques taught)
- Pediatric patients \< 18 years of age
- Patients with contraindications to intra-op protocol
- Patients with contraindications to auricular acupuncture (non-native ear, active ear infection, gauges in the ears)
- Patients unable/unwilling to participate in the questionnaires or view the scripted intervention
- Patients scheduled for consecutive or staged surgeries
- Patients allergic to local anesthetics or study medications
- Patients who have kidney disease
Key Trial Info
Start Date :
February 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06180486
Start Date
February 2 2024
End Date
February 11 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021